Ebrahim Versi's Insider Trades & SAST Disclosures

Ebrahim Versi's most recent trade in DMK Pharmaceuticals Corp was a trade of 177,194 Common Stock done . Disclosure was reported to the exchange on May 25, 2023.

Share

Note

This is a custom search result for pattern Ebrahim Versi.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
DMK Pharmaceuticals Corp	Ebrahim Versi	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2023	177,194	177,194 (0%)	0%		-	Common Stock
DMK Pharmaceuticals Corp	Ebrahim Versi	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2023	20,577	20,577	-		-	Employee Stock Option (Right to Buy)
DMK Pharmaceuticals Corp	Ebrahim Versi	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2023	20,577	20,577	-		-	Employee Stock Option (Right to Buy)
DMK Pharmaceuticals Corp	Ebrahim Versi	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2023	20,577	20,577	-		-	Employee Stock Option (Right to Buy)
DMK Pharmaceuticals Corp	Ebrahim Versi	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2023	20,577	20,577	-		-	Employee Stock Option (Right to Buy)
DMK Pharmaceuticals Corp	Ebrahim Versi	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2023	20,577	20,577	-		-	Employee Stock Option (Right to Buy)
DMK Pharmaceuticals Corp	Ebrahim Versi	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2023	8,745	8,745 (0%)	0%		-	Common Stock
DMK Pharmaceuticals Corp	Ebrahim Versi	Director, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 May 2023	1,941	1,941	-		-	Series E Convertible Preferred Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades